These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 15979441)
21. Effects of atorvastatin on arterial endothelial function in coronary bypass surgery. Chello M; Goffredo C; Patti G; Candura D; Melfi R; Mastrobuoni S; Di Sciascio G; Covino E Eur J Cardiothorac Surg; 2005 Dec; 28(6):805-10. PubMed ID: 16274999 [TBL] [Abstract][Full Text] [Related]
22. Effect of a single IV administration of L-propionylcarnitine on myocardial microcirculation assessed by coronary flow velocity reserve measurement in patients with systemic sclerosis: a pilot study. Montisci R; Ruscazio M; Lai S; Vacca A; Cauli A; Passiu G; Montisci M; Meloni L; Mathieu A; Iliceto S Clin Ther; 2007 Jan; 29(1):163-71. PubMed ID: 17379056 [TBL] [Abstract][Full Text] [Related]
24. Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease--a randomized, placebo-controlled study. Alber HF; Frick M; Suessenbacher A; Doerler J; Schirmer M; Stocker EM; Dichtl W; Pachinger O; Weidinger F Am Heart J; 2006 Jan; 151(1):139. PubMed ID: 16368305 [TBL] [Abstract][Full Text] [Related]
25. Integrin expression on monocytes and lymphocytes in unstable angina short term effects of atorvastatin. Dobreanu M; Dobreanu D; Fodor A; Bacarea A Rom J Intern Med; 2007; 45(2):193-9. PubMed ID: 18333374 [TBL] [Abstract][Full Text] [Related]
26. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension. Kosmidou MS; Hatzitolios AI; Adamidou A; Giannopoulos S; Raikos N; Parharidis G; Milionis HJ Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666 [TBL] [Abstract][Full Text] [Related]
27. [Noninvasive assessment of the effect of atorvastatin on coronary microvasculature and endothelial function in patients with dyslipidemia]. Tomás JP; Moya JL; Campuzano R; Barrios V; Megías A; Ruiz S; Catalán P; Recarte MA; Muriel A Rev Esp Cardiol; 2004 Oct; 57(10):909-15. PubMed ID: 15469787 [TBL] [Abstract][Full Text] [Related]
29. [Atorvastatin use and coronary flow reserve in patients with coronary slow flow]. Fan Y; Yang SS; Yu JB; Hao JH; Han W; Gan RT; Wang Z; Li WM; Huang YL Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Feb; 38(2):143-6. PubMed ID: 20398561 [TBL] [Abstract][Full Text] [Related]
30. Von Willebrand disease and angiodysplasia responding to atorvastatin. Sohal M; Laffan M Br J Haematol; 2008 Jun; 142(2):308-9. PubMed ID: 18510690 [No Abstract] [Full Text] [Related]
31. Atorvastatin: in the management of hyperlipidaemia. Ray SK; Rege NN J Postgrad Med; 2000; 46(3):242-3. PubMed ID: 11298482 [No Abstract] [Full Text] [Related]
32. Low-density lipoprotein-independent improvement of flow-mediated dilatation with atorvastatin: a meta-analysis and meta-regression of randomized controlled trials. Takagi H; Yamamoto H; Iwata K; Goto SN; Umemoto T Int J Cardiol; 2012 Jul; 158(2):285-9. PubMed ID: 22560909 [No Abstract] [Full Text] [Related]
33. Assessment of regional systolic and diastolic functions affected by atorvastatin in coronary artery disease using tissue Doppler imaging. Qie L; Meng X; Wang Y; Feng M; Zhong M; Li L Clin Cardiol; 2008 Nov; 31(11):551-5. PubMed ID: 18727111 [TBL] [Abstract][Full Text] [Related]
34. Direct demonstration by transthoracic Doppler echocardiography of adenosine-induced coronary steal in the collateral-dependent vessel. Takeuchi M; Yoshitani H; Otani S; Yoshikawa J Am J Cardiol; 2005 Jun; 95(11):1363-6. PubMed ID: 15904645 [TBL] [Abstract][Full Text] [Related]
35. Assessment of arterial stiffness affected by atorvastatin in coronary artery disease using pulse wave velocity. Meng X; Qie L; Wang Y; Zhong M; Li L Clin Invest Med; 2009 Dec; 32(6):E238. PubMed ID: 20003828 [TBL] [Abstract][Full Text] [Related]
36. Serotonin transporter protein in pulmonary hypertensive rats treated with atorvastatin. Laudi S; Trump S; Schmitz V; West J; McMurtry IF; Mutlak H; Christians U; Weimann J; Kaisers U; Steudel W Am J Physiol Lung Cell Mol Physiol; 2007 Sep; 293(3):L630-8. PubMed ID: 17575010 [TBL] [Abstract][Full Text] [Related]
37. Effect of azithromycin therapy on coronary circulation in patients with coronary artery disease. Hyodo E; Hozumi T; Takemoto Y; Fujimoto K; Watanabe H; Muro T; Shimada K; Akioka K; Yoshiyama M; Takeuchi K; Yoshikawa J Am J Cardiol; 2004 Dec; 94(11):1426-9. PubMed ID: 15566918 [TBL] [Abstract][Full Text] [Related]
38. Atorvastatin and portal pressure. Zamora-Valdés D; Uribe M; Méndez-Sánchez N Hepatology; 2007 Oct; 46(4):1309-10; author reply 1310. PubMed ID: 17894304 [No Abstract] [Full Text] [Related]
39. [Fluctuation of C-reactive protein levels in acute coronary syndrome]. Kadzhaia GV Georgian Med News; 2005 Nov; (128):41-4. PubMed ID: 16369062 [TBL] [Abstract][Full Text] [Related]
40. Rationale and design for the SARIS trial; effect of statin on atherosclerosis and vascular remodeling assessed with intravascular sonography. Effect of Statin on Atherosclerosis and vascular Remodeling assessed with Intravascular Sonography. Hagenaars T; Gussenhoven EJ; Poldermans D; van Urk H; van der Lugt A Cardiovasc Drugs Ther; 2001 Jul; 15(4):339-43. PubMed ID: 11800418 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]